{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:49:34Z","timestamp":1773280174904,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Neonatal hypertrophic cardiomyopathy (HCM) is an idiopathic disease characterised by myocardial hypertrophy with normal or small ventricular chambers, a systolic hyperdynamic state and diastolic dysfunction. The etiology, pathogenesis and clinical manifestations of HCM are diverse, and it is likely to progress to sudden cardiac death. The highly heterogeneous nature of this disease determines the difficulty of its diagnosis, and it is especially rare to report that can be diagnosed conclusively in the neonatal period. However, when it does occur, the younger the age of onset is, the higher the mortality rate and the worse the prognosis. The genetic variants and diagnostic timing can affect the life course of the patient. This case report describes a neonate with a family history of HCM who was diagnosed with hypertrophic non-obstructive cardiomyopathy by echocardiography shortly after birth. At 4 years of age, the patient presented with slow weight gain, feeding difficulties, tachypnoea and diaphoresis, and cardiac ultrasound findings suggesting progression to severe hypertrophic obstructive cardiomyopathy, with a high likelihood of arrhythmias, heart failure, pulmonary hypertension, syncope and even sudden death. Neonatal congenital hypertrophic cardiomyopathy is extremely rare and difficult to diagnose before the onset of symptoms. Echocardiography has a definite diagnostic value in hypertrophic cardiomyopathy and helps in early detection and treatment. At the time of clinical diagnosis, children with hypertrophic cardiomyopathy should be asked about their family history and, if necessary, a survey of family members should be conducted for the early detection of mildly ill patients and gene carriers to enable timely intervention and treatment, which remains the focus of our research and efforts.<\/jats:p>","DOI":"10.3389\/fped.2023.1295539","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T05:36:13Z","timestamp":1701236173000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Neonatal hypertrophic cardiomyopathy with dyspnoea as the first symptom: a case report"],"prefix":"10.3389","volume":"11","author":[{"given":"Xiaoxia","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Jun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Qun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1213\/ANE.0000000000000538","article-title":"Hypertrophic cardiomyopathy: a review","volume":"120","author":"Hensley","year":"2015","journal-title":"Anesth Analg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/02184923211041285","article-title":"Hypertrophic cardiomyopathy in children","volume":"30","author":"Wang","year":"2022","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"B3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jacc.2021.11.021","article-title":"Management of hypertrophic cardiomyopathy: JACC state-of-the-art review","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1161\/CIR.0000000000000938","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American college of cardiology \/American heart association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American heart association","volume":"140","author":"Lipshultz","year":"2019","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/head.12246","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"53","author":"Gagnier","year":"2013","journal-title":"Headache"},{"key":"B8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7861\/clinmedicine.19-1-61","article-title":"Cardiology: hypertrophic cardiomyopathy","volume":"19","author":"Firth","year":"2019","journal-title":"Clin Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/s0735-1097(03)00855-6","article-title":"Clinical course of hypertrophic cardiomyopathy with survival to advanced age","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.amjcard.2009.07.057","article-title":"Prognostic implications of the Doppler restrictive \ufb01lling pattern in hypertrophic cardiomyopathy","volume":"104","author":"Biagini","year":"2009","journal-title":"Am J Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12916-021-02219-7","article-title":"Identification of heart failure with preserved ejection fraction helps risk strati\ufb01cation for hypertrophic cardiomyopathy","volume":"20","author":"Liu","year":"2022","journal-title":"BMC Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.4070\/kcj.2021.0153","article-title":"Hypertrophic cardiomyopathy in infants from the perspective of cardiomyocyte maturation","volume":"51","author":"Seok","year":"2021","journal-title":"Korean Circ J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2165\/00148581-200305100-00002","article-title":"Management of hypertrophic cardiomyopathy in children","volume":"5","author":"Seggewiss","year":"2003","journal-title":"Paediatr Drugs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/VHRM.S365001","article-title":"Familial hypertrophic cardiomyopathy: diagnosis and management","volume":"19","author":"Litt","year":"2023","journal-title":"Vasc Health Risk Manag"},{"key":"B16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.acvd.2014.12.002","article-title":"Recommendations for the diagnosis and management of hypertrophic cardiomyopathy in 2014","volume":"108","author":"Dubourg","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1161\/CIRCULATIONAHA.120.050384","article-title":"East Asian-speci\ufb01c common variant in TNNI3 predisposes to hypertrophic cardiomyopathy","volume":"142","author":"Wu","year":"2020","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity","volume":"53","author":"Harper","year":"2021","journal-title":"Nat Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular genetic basis of hypertrophic cardiomyopathy","volume":"128","author":"Marian","year":"2021","journal-title":"Circ Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.jacc.2007.02.061","article-title":"Prevalence, clinical signi\ufb01cance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype","volume":"49","author":"Kubo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s41687-020-00269-8","article-title":"Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life","volume":"4","author":"Zaiser","year":"2020","journal-title":"J Patient Rep Outcomes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8 080 adults","volume":"116","author":"Zou","year":"2004","journal-title":"Am J Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1295539\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T05:36:15Z","timestamp":1701236175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1295539\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":24,"alternative-id":["10.3389\/fped.2023.1295539"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1295539","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"article-number":"1295539"}}